- Home
- AUTL vs CHCT Comparison
AUTL vs CHCT Comparison
Compare AUTL & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- CHCT
- Stock Information
- Founded
- AUTL 2014
- CHCT 2014
- Country
- AUTL United Kingdom
- CHCT United States
- Employees
- AUTL N/A
- CHCT N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- CHCT Real Estate Investment Trusts
- Sector
- AUTL Health Care
- CHCT Real Estate
- Exchange
- AUTL Nasdaq
- CHCT Nasdaq
- Market Cap
- AUTL 359.3M
- CHCT 422.2M
- IPO Year
- AUTL 2018
- CHCT 2015
- Fundamental
- Price
- AUTL $2.26
- CHCT $16.24
- Analyst Decision
- AUTL Strong Buy
- CHCT Buy
- Analyst Count
- AUTL 5
- CHCT 4
- Target Price
- AUTL $9.32
- CHCT $21.00
- AVG Volume (30 Days)
- AUTL 2.6M
- CHCT 196.6K
- Earning Date
- AUTL 05-08-2025
- CHCT 07-29-2025
- Dividend Yield
- AUTL N/A
- CHCT 11.48%
- EPS Growth
- AUTL N/A
- CHCT N/A
- EPS
- AUTL N/A
- CHCT N/A
- Revenue
- AUTL $9,011,000.00
- CHCT $116,531,000.00
- Revenue This Year
- AUTL $329.53
- CHCT $7.14
- Revenue Next Year
- AUTL $191.73
- CHCT $7.04
- P/E Ratio
- AUTL N/A
- CHCT N/A
- Revenue Growth
- AUTL N/A
- CHCT 1.33
- 52 Week Low
- AUTL $1.11
- CHCT $14.76
- 52 Week High
- AUTL $5.00
- CHCT $27.62
- Technical
- Relative Strength Index (RSI)
- AUTL 80.26
- CHCT 46.40
- Support Level
- AUTL $1.19
- CHCT $16.16
- Resistance Level
- AUTL $1.79
- CHCT $16.67
- Average True Range (ATR)
- AUTL 0.13
- CHCT 0.35
- MACD
- AUTL 0.08
- CHCT 0.02
- Stochastic Oscillator
- AUTL 98.98
- CHCT 47.33
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.